Treximet Approval History 
- FDA approved: Yes (First approved April 15th, 2008)
- Brand name: Treximet
- Generic name: sumatriptan succinate and naproxen sodium
- Previous name: Trexima
- Company: Pozen Inc.
- Treatment for: Migraine
Treximet is a combination of sumatriptan (a migraine-specific triptan) and naproxen (an anti-inflammatory pain reliever) in a single tablet for the acute treatment of migraine.
FDA Approval History for Treximet
| Date | Article |
|---|
| Apr 16, 2008 |  Treximet (sumatriptan and naproxen sodium) Tablets Approved by FDA
for Acute Treatment of Migraine |
| Jan 16, 2008 | Pozen Submits Human Lymphocyte Study for Treximet (Formerly Known
as Trexima) |
| Nov 1, 2007 | Pozen Announces Trexima (Sumatriptan Succinate and Naproxen Sodium)
Amended Response Accepted for Review by FDA |
| Oct 15, 2007 | Pozen Submits Response to Approvable Letter for Trexima |
| Oct 5, 2007 | Pozen Plans to Submit Response to Approvable Letter For Trexima
Within the Next Ten Days |
| Aug 2, 2007 | FDA Issues Second Approvable Letter for Trexima |
| Mar 22, 2007 | Pozen Announces Trexima (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA |
| Dec 13, 2006 | Pozen Expects to Submit Revised Response to Trexima Approvable Letter by Year End |
| Nov 9, 2006 | Pozen Submits Full Response to FDA Approvable Letter For Trexima |
| Jul 31, 2006 | Pozen to Submit Full Response to Trexima Approvable Letter During the Fourth Quarter |
| Jun 9, 2006 | Pozen Inc. and GlaxoSmithKline Report Receipt of Approvable Letter for Investigational Migraine Treatment |
| Oct 11, 2005 | GlaxoSmithKline and POZEN Announce Trexima (Sumatriptan Succinate and Naproxen Sodium) New Drug Application Accepted for Review by FDA |
| Aug 8, 2005 | POZEN Submits New Drug Application for Trexima (Sumatriptan Succinate and Naproxen Sodium) for the Acute Treatment of Migraine |
See also...
Treximet (sumatriptan succinate and naproxen sodium) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
